Search results
Novo Nordisk's Stock Dips After Second Fire Hits Danish Facilities By Quiver Quantitative
Investing.com· 2 days agoNovo Nordisk (CSE:NOVOb) (NVO), the maker of popular weight-loss and diabetes treatments Ozempic and...
Novo Nordisk Hit by Fire in Denmark For Second Time in One Week
Bloomberg· 2 days agoA Novo Nordisk A/S facility has caught fire at one of the drugmaker’s sites in Denmark, in the...
Map shows mystery fires at NATO states' industrial hubs amid sabotage woes
Newsweek· 7 hours agoOn Thursday, a scrap metal facility in Hamburg's port area ignited a day after the fire department...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk,...
Zacks via Yahoo Finance· 1 day agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
Benzinga· 2 days agoThe FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to meet on May 24 to...
Novo reports 'really powerful' cardio, death risk reduction for semaglutide in kidney disease
Endpoints News· 6 hours agoNovo Nordisk’s semaglutide cut the risk of major cardiovascular events and death from multiple...
Novo Nordisk's experimental weekly insulin comes with a higher risk of low blood sugar, warns FDA
Quartz· 2 days agoStaff at the U.S. Food and Drug Administration (FDA) said on Wednesday that Novo Nordisk’s...
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
Benzinga via AOL· 2 days agoThe FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to meet on May 24 to...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk,...
Zacks· 2 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Novo
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
NBC Washington· 3 days agoThe rivalry between Eli Lilly and Novo Nordisk extends beyond a buzzy class of weight loss and...